ARTICLE | Company News
Enzon, SGP get European marketing approval
March 28, 2001 8:00 AM UTC
ENZN partner Schering-Plough (SGP) received European marketing authorization for Pegintron peginterferon alfa-2b in combination with SGP's Rebetol ribavirin capsules as a combination therapy to treat ...